Form 4 for ETON Eton Pharmaceuticals, Inc.
Accepted 2026-08-20 18:26:19 ET · period of report 2026-08-19 · accession 0001437749-26-028651 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-08-20 18:26 | 2026-08-19+ | ETON | BRYNJELSEN SEAN | Pres, CEO, Dir | S - Sale | $60.88 | -100.0K | 961.2K | -9% | -$6.09M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-19 | S | D | 8,978 | $62.65 | 1,052,216 | D | — | — | (F1) The shares were sold in multiple trades at prices ranging from $62.50 to $63.41. The price above reflects the weighted average sales price. (F2) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2026-08-20 | S | D | 47,307 | $60.17 | 1,004,909 | D | — | — | (F2) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F3) The shares were sold in multiple trades at prices ranging from $59.59 to $60.59. The price above reflects the weighted average sales price. |
| 3 | Common | Common Stock | 2026-08-20 | S | D | 36,373 | $61.11 | 968,536 | D | — | — | (F2) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F4) The shares were sold in multiple trades at prices ranging from $60.61 to $61.61. The price above reflects the weighted average sales price. |
| 4 | Common | Common Stock | 2026-08-20 | S | D | 7,342 | $62.12 | 961,194 | D | — | — | (F2) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F5) The shares were sold in multiple trades at prices ranging from $61.63 to $62.52. The price above reflects the weighted average sales price. |